Nasdaq-100® Inside the Index: Synopsys (SNPS)
Key Figures
- $7.05B FY2025 revenue
- +42% revenue growth (Q2 FY2026, YoY)
- 39.5% non-GAAP operating margin (Q2 FY2026)
- ~25× forward P/E
- 26,750 employees
VOL 1 • ISSUE 12 • SEPTEMBER 2026
Every advanced chip is designed in software long before it is manufactured. Synopsys licenses that software by the year.
SNPS • TECHNOLOGY • INDEX CONSTITUENT
This Issue — SNPS
Synopsys, a current Nasdaq-100® constituent at ~0.34% index weight, sells the software used to design semiconductors: engineers lay out circuits, verify them, and review them inside Synopsys tools before anything reaches a factory. It also licenses ready-made circuit blocks, called design IP, that customers drop into their own chips. Most of the money arrives as time-based licenses and support contracts rather than as a royalty on chips sold (per company filings). The July 2025 purchase of Ansys added engineering simulation, the software engineers use to test how a physical product behaves before it is built.
Business Model & Revenue Drivers
What Synopsys Actually Sells
A modern chip holds billions of transistors, so no one draws it by hand. Designers work inside electronic design automation software, and Synopsys is the largest supplier of it, selling the tools that lay out circuits, simulate them, and check them before a factory commits to silicon. Alongside the tools, it licenses design IP, pre-built circuit blocks a customer can drop into its own chip rather than build from scratch.
The economics sit in how those licenses are written. Time-based licenses carried $3.73B of trailing-twelve-month revenue to April 2026, with another $2.53B in maintenance and services, against $2.42B billed upfront (per company filings). Customers pay for access over a term, so revenue is closely tied to how much design work the industry funds rather than to how many finished chips sell.
Revenue by license type (12 months to April 2026): Time-based $3.73B • Upfront $2.42B (plus $2.53B maintenance and services).
Competitive Moat
Why This Is Hard to Replicate
Chip design software has to be trusted before it is bought. A tool that misses a defect costs a customer a fabrication run, so design teams certify a vendor's flow with a foundry and keep it for years. Synopsys holds an estimated 37% of the $11.3 billion market for chip design software, and 80% of chip prototyping, where its systems let engineers run software on a chip that does not physically exist yet (per Bloomberg research estimates).
Two things deepen that position. Synopsys spent $2.48B on research and development in FY2025, and it certifies flows directly with the foundries, including AI-powered flows on Intel's 14A process in July 2026 and 2nm flows with Samsung Foundry. Each certification is work a rival would repeat node by node.
Share of the $11.3B chip design software market (per Bloomberg research estimates): Synopsys 37% • All others 63%.
Operating Strengths
Three Structural Advantages
- ~80% chip prototyping share (est.). Estimated share in prototyping, plus 45–55% in emulation, the step where a design is tested at speed (per Bloomberg research estimates).
- 42% design and simulation share (est.). Estimated combined share of simulation and chip design software after the July 2025 Ansys purchase (per Bloomberg research estimates).
- $2.48B FY2025 R&D spending. Up from $1.50B in FY2021, tracking revenue over the same five years (per company filings).
Growth Catalysts
Where the Business Goes Next
Software that does the design work itself is the near-term story. Synopsys has built agentic tools that run long jobs on their own across digital design, verification, and physical implementation. Its verification agent, shown at DAC 2026, claims up to 50 times faster time to validated register-transfer level code and 20% additional coverage against conventional methods (company disclosures). Pricing is a subscription plus a consumption charge, with 20 customers evaluating across 25 or more specialized agents, so adoption at scale represents upside rather than booked revenue today.
- Multiphysics Fusion. The first solutions combining AI-powered design tools with Ansys signoff analysis became available in mid-2026, with revenue monetization expected to begin in FY2027 (company disclosures).
- Foundry ramps. No incremental Intel revenue is included in FY2026 guidance, so a 14A ramp on the certified flows would represent potential upside; Samsung Foundry collaboration expanded to 2nm production flows.
- Customer R&D budgets. Semiconductor research spending is expected to grow 26% year over year in 2026, with AI-related research up 31%, a measure that has historically correlated with Synopsys revenue (per Bloomberg research estimates).
Historical Context
FY2021 – FY2025 Revenue Trajectory
+68% FY2021–FY2025 revenue growth
Revenue rose in each of the five years from FY2021 through FY2025, compounding at roughly 13.8% a year while research spending rose alongside it. FY2024 net income was elevated by gains tied to the Ansys transaction, so the earnings line moves less smoothly than revenue. FY2026 is the first full year that includes Ansys and is an expectation, not a result (company guidance and consensus estimates).
- FY2021: $4.20B
- FY2022: $5.08B (+20.9%)
- FY2023: $5.84B
- FY2024: $6.13B
- FY2025: $7.05B
- FY2026E: $9.69B (Ansys year 1)
- R&D spending (FY2021 → FY2025): $1.50B → $2.48B, +65%
- EBITDA (FY2021 → FY2025): $1.28B → $3.29B, +157%
- Core design software revenue (Q2 FY2026, YoY): +8%, on advanced node and 3D chip demand
Source: Synopsys filings; FY2026E per company guidance and Bloomberg consensus estimates.
Chips are designed years before they ship. Synopsys is paid during the designing.
Valuation & Investment Thesis
Priced on Normalized Earnings
Synopsys trades at ~25× forward earnings, below its own five-year average forward multiple of 35× (per Bloomberg research estimates). The trailing multiple of 104.5× is not the useful number here: Ansys integration charges and purchase accounting depress reported GAAP earnings, which is why the forward basis is the cleaner read.
What a buyer gets at that price is FY2026 revenue guidance of $9.625B to $9.705B and adjusted earnings of $14.72 to $14.80 a share (company guidance, raised May 2026). There is no dividend; cash is going to debt reduction after Ansys and a $300M repurchase program.
Key Risks
What Could Change the Story
- Design IP softness, with the segment down 6.5% in Q1 FY2026 and recovery to low-double-digit growth possibly delayed.
- China exposure, where revenue has fallen from a peak of ~17% of the total in FY2024 to below 10% in FY2026 under export restrictions.
- Intel roadmap dependence, since scaled-back customer ambitions on Intel 18A and 14A disrupt the economics of the IP business.
- Ansys integration, which added substantial debt and leaves synergy delivery and channel accounting as execution risks.
- Customer concentration, with the top 10 customers at approximately 30% of revenue, so budget tightening lands hard.
What This Means For You
The Index Angle, in Plain Terms
In your index fund — If you hold a fund that tracks the Nasdaq-100 Index®, you already own this.
- Index composition follows transparent eligibility criteria, and SNPS is a current constituent at ~0.34% index weight: roughly 34 cents of every $100 tracking the Nasdaq-100 sits in Synopsys.
- The processor in your phone and the accelerators in an AI data center are systems-on-a-chip, and chips like these are laid out and verified in design software before a factory builds them.
- Synopsys is paid for the design stage, mostly on time-based licenses, so its revenue tracks how much the industry is designing.
Decoding the Jargon
Two terms doing the heavy lifting in this issue.
- EDA (electronic design automation). The software chip engineers design and test inside. Synopsys holds an estimated 37% of that $11.3 billion market, which is why its results read as a gauge of industry design activity.
- Forward P/E. Price divided by the earnings a company is expected to make next year, rather than last year's. At ~25× forward
Bottom Line
Inside the Nasdaq-100®, Synopsys sits one step before the chips themselves. It is paid for the designing, not for the shipping.
About the Series
The Nasdaq-100® is a globally recognized index of 100 of the most innovative large cap companies listed on the Nasdaq Stock Market®. The Inside the Index series profiles one constituent each issue, from software to soft drinks and computer chips to potato chips, exploring what makes each business distinctive and the metrics investors should know.
Sources
Disclaimer
Nasdaq®, Nasdaq-100®, Nasdaq-100 Index®, Nasdaq Stock Market®, and NDX® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing.
Information set forth contains forward-looking statements that involve a number of risks and uncertainties. Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information. Forward-looking statements can be identified by words such as "will," "believe" and other words and terms of similar meaning. Such forward-looking statements include, but are not limited to, statements related to listing on Nasdaq. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These risks and uncertainties are detailed in Nasdaq's filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q which are available on Nasdaq's investor relations website at http://ir.nasdaq.com and the SEC's website at www.sec.gov. Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
© 2026. Nasdaq, Inc. All Rights Reserved.